文献速递心力衰竭与心肌病

瘦素-醛固酮-脑啡肽酶轴:在肥胖者三种心衰表型发病机制中的独特作用

Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity.
PubMed 文献 · Circulation · 2018-01-01

综述提出肥胖(尤其内脏脂肪)相关三种心衰表型(射血分数降低、保留及高输出量心衰)均以醛固酮过度分泌和钠潴留为特征。瘦素与醛固酮的有害交互经脂肪与肾交感神经增强脑啡肽酶活性,加剧利钠肽代偿丧失,导致血浆容量扩张及不良心室重构和纤维化;该轴激活参与肥胖者心衰发生进展,干预此神经激素生态系统可能带来独特临床获益。

要点

  • 肥胖相关三种心衰表型均存在醛固酮过度分泌和钠潴留。
  • 瘦素与醛固酮交互经脂肪和肾交感神经增强脑啡肽酶活性。
  • 该轴激活导致血浆容量扩张、不良心室重构和心脏纤维化。

核心结论

  • 无论表型如何,瘦素-醛固酮-脑啡肽酶轴激活似在肥胖者心衰发生和进展中起重要作用。
  • 干预该神经激素生态系统中有害交互的现有或新型治疗药物可能产生独特临床获益。

研究设计与样本

  • 本文为综述,检索范围未在摘要中报告。

主要发现

  • 肥胖(尤其内脏脂肪)可伴三种心衰表型:射血分数降低、射血分数保留和高输出量心衰。
  • 三种表型均以醛固酮过度分泌和钠潴留为特征。
  • 肥胖伴瘦素受体信号增强,可促进交感神经系统和肾素-血管紧张素系统激活并直接刺激醛固酮分泌。
  • 脂肪与肾交感神经同时作用增强瘦素与醛固酮的有害交互,导致脑啡肽酶过度活跃;肥胖和心衰干扰脂联素信号加剧利钠肽代偿作用丧失。
  • 该神经激素交互导致血浆容量扩张以及不良心室重构和心脏纤维化;醛固酮和脑啡肽酶活性增强还可促进脂肪生成和脂肪细胞功能障碍,形成正反馈循环。

临床怎么用

  • 对肥胖心衰患者应认识瘦素-醛固酮-脑啡肽酶轴激活在三种表型中的共同致病作用。
  • 针对该神经激素交互的现有或新型治疗药物可能为肥胖心衰患者带来独特临床获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity (especially visceral adiposity) can be associated with 3 different phenotypes of heart failure: heart failure with a reduced ejection fraction, heart failure with a preserved ejection fraction, and high-output heart failure. All 3 phenotypes are characterized by an excessive secretion of aldosterone and sodium retention. In addition, obesity is accompanied by increased signaling through the leptin receptor, which can promote activation of both the sympathetic nervous system and the renin-angiotensin system and can directly stimulate the secretion of aldosterone. The deleterious interaction of leptin and aldosterone is potentiated by the simultaneous action of adiposity and the renal sympathetic nerves to cause overactivity of neprilysin; the loss of the counterbalancing effects of natriuretic peptides is exacerbated by an additional effect of both obesity and heart failure to interfere with adiponectin signaling. This intricate neurohormonal interplay leads to plasma volume expansion as well as to adverse ventricular remodeling and cardiac fibrosis. Furthermore, the activity of aldosterone and neprilysin is not only enhanced by obesity, but these mechanisms can also promote adipogenesis and adipocyte dysfunction, thereby enhancing the positive feedback loop. Last, in elderly obese women, changes in quantity and biology of epicardial adipose tissue further enhances the release of leptin and other proinflammatory adipokines, thereby leading to cardiac and systemic inflammation, end-organ fibrosis, and multiple comorbidities. Regardless of the phenotypic expression, activation of the leptin-aldosterone-neprilysin axis appears to contribute importantly to the evolution and progression of heart failure in people with obesity. Efforts to interfere with the detrimental interactions of this distinctive neurohormonal ecosystem with existing or novel therapeutic agents are likely to yield unique clinical benefits.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Packer M. Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity. Circulation. 2018. PMID: 29632154. doi:10.1161/CIRCULATIONAHA.117.032474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。